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Background: Accurate diagnosis and prompt treatment of pregnancy-associated malaria (PAM) are key aspects in
averting adverse pregnancy outcomes. Microscopy is the gold standard in malaria diagnosis, but it has limited
detection and availability. When used appropriately, rapid diagnostic tests (RDTs) could be an ideal diagnostic
complement to microscopy, due to their ease of use and adequate sensitivity in detecting even sub-microscopic
infections. Polymerase chain reaction (PCR) is even more sensitive, but it is mainly used for research purposes.
The accuracy and reliability of RDTs in diagnosing PAM was evaluated using microscopy and PCR.
Methods: A cohort of pregnant women in north-eastern Tanzania was followed throughout pregnancy for
detection of plasmodial infection using venous and placental blood samples evaluated by histidine rich protein 2
(HRP-2) and parasite lactate dehydrogenase (pLDH) based RDTs (Parascreen™) or HRP-2 only (Paracheck PfW and
ParaHITWf), microscopy and nested Plasmodium species diagnostic PCR.
Results: From a cohort of 924 pregnant women who completed the follow up, complete RDT and microscopy
data was available for 5,555 blood samples and of these 442 samples were analysed by PCR. Of the 5,555 blood
samples, 49 ((proportion and 95% confidence interval) 0.9% [0.7 -1.1]) samples were positive by microscopy and
91 (1.6% [1.3-2.0]) by RDT. Forty-six (50.5% [40.5 - 60.6]) and 45 (49.5% [39.4 – 59.5]) of the RDT positive samples
were positive and negative by microscopy, respectively, whereas nineteen (42.2% [29.0 - 56.7]) of the microscopy
negative, but RDT positive, samples were positive by PCR. Three (0.05% [0.02 - 0.2]) samples were positive by
microscopy but negative by RDT. 351 of the 5,461 samples negative by both RDT and microscopy were tested
by PCR and found negative. There was no statistically significant difference between the performances of the
different RDTs.
Conclusions: Microscopy underestimated the real burden of malaria during pregnancy and RDTs performed better
than microscopy in diagnosing PAM. In areas where intermittent preventive treatment during pregnancy may be
abandoned due to low and decreasing malaria risk and instead replaced with active case management, screening
with RDT is likely to identify most infections in pregnant women and out-performs microscopy as a diagnostic tool.
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Accurate diagnosis and prompt treatment of pregnancy-
associated malaria (PAM) is essential to avert adverse
pregnancy outcomes [1]. Detection of sub-microscopic
infections is crucial in order to not only effect prompt
treatment of asymptomatic cases, but also to identify and
clear potential reservoirs of transmission [2,3] and to re-
duce malaria related morbidity and mortality. Presumptive
treatment of malaria based on clinical diagnosis is rela-
tively cheap but it is unreliable due to overlapping symp-
toms with non-malarial infections caused by viruses or
bacteria [4] and could lead to over-diagnosis [5] as well.
Wrong diagnoses may lead to presumptive medication
and hence many patients may leave the health facility
without the right treatment. Rational prescription of anti-
malarials is not only important in saving on the cost of ex-
pensive drugs but it also prevents drug overuse that
might result in the development of resistance [6]. Sub-
microscopic infections during pregnancy might be asso-
ciated with increased risk of adverse pregnancy outcomes
including low birth weight babies and maternal anaemia
[7,8]. Therefore, treatment of these infections may pre-
vent potential risks of adverse pregnancy outcome [9].
PAM in the sub-Saharan Africa is caused by Plasmo-
dium falciparum, and it is precipitated because VAR2CSA,
member of the P. falciparum erythrocyte membrane pro-
tein 1 (PfEMP-1) family expressed on the surface of
infected erythrocytes (IEs) mediates sequestration of IEs in
the intervillous spaces of the placenta by binding to chon-
droitin sulphate A (CSA) receptors [10,11]. The pathogen-
esis of PAM and its association with adverse pregnancy
outcome [12,13], such as intrauterine growth retardation
and low birth weight is not well understood but it is
thought to be caused by impairment in nutrient transport
to the foetus [14], with possible effects on growth regulat-
ing hormones [15] and trophoblast invasion [16]. As a re-
sult of placental sequestration it is often difficult to detect
IEs in the peripheral blood using microscopy [17]. Fur-
thermore, malarial infections are usually asymptomatic
among adults in malaria endemic regions, decreasing the
chances of clinical detection by using clinical algorithms.
Primi- and secundigravidae as opposed to multigravidae
are most affected as they lack sufficient previous exposure
to allow the development of protective immunity [18,19].
Microscopic examination of blood smears has been the
gold standard for malaria diagnosis but it is compromised
by poor infrastructure and the need for individuals with
expertise in microscopy who are not necessarily available
in many health facilities in malaria endemic regions [20].
Furthermore, microscopy is not sensitive enough [5,9,21-
24], it requires good quality reagents, well maintained
microscopes, and is time consuming [25]. Studies con-
ducted in many malaria endemic regions show better
sensitivity of RDTs as compared to microscopy [26-29]in malaria diagnosis and it is suggested that RDTs could
be used as a supplementary diagnostic tool to aid
evidence-based decision making in malaria treatment.
The use of RDTs requires neither extensive training [30]
nor substantial investment in infrastructure as compared
to microscopy. However, there are a number of chal-
lenges that need to be addressed for optimal and effect-
ive utilization of RDTs in malaria diagnosis in order to
provide reliable and credible diagnoses [31]. There
should among others be; frequent quality controls and
assurances, optimal storage conditions as well as updates
on newly available or improved RDTs. If proper instruc-
tions are not given to staff especially in the rural com-
munities on how to properly handle these RDTs, their
expected usefulness as an alternative diagnostic tool for
malaria diagnosis would be highly compromised.
The performance of Parascreen™ has previously been
assessed under field conditions [32] involving children
with clinical suspicion of malaria in a rural area of Kenya
and gave results that were in agreement with other mal-
arial diagnostic tests. Likewise, Paracheck PfW and Para-
HITWf have also been assessed in community studies
within the study area [33,34]. However, during these
cross-sectional and longitudinal community studies [33]
it has been shown that Paracheck PfW and ParaHITWf
which are HRP-2 based RDTs were not very sensitive in
diagnosing parasite densities of less than 200 asexual
stages/μl in asymptomatic children. The sensitivity of
different RDTs can also be improved by increasing the
concentration of detection antibodies. This is an import-
ant component in the manufacturing process, which is
usually coupled by frequent evaluations of test perfor-
mances. Nevertheless their use, despite the low sensitiv-
ity at very low parasitaemia has significantly reduced
over-prescription of anti-malarials among individuals
without malarial infection and they performed well in
diagnosing those with symptoms of malaria [5].
Many studies that assess the sensitivity and specificity
of RDTs of malaria mainly utilize microscopy as the gold
standard [35-37]. However, RDTs detecting histidine rich
protein 2 (HRP-2) have the problem of detecting HRP-2
antigen circulating in the blood more than two weeks
after IEs have been cleared from the blood stream,
resulting in high false positive rates [38,39]. In the study
presented here, RDTs that detect both HRP-2 and pLDH
as well as HRP-2 only antigens were used in order to
detect P. falciparum infections, and to also identify non-
falciparum species in the area [40].
Other sensitive alternative tests superior to microscopy
and RDTs such as PCR and real-time quantitative
nucleic acid sequence-based amplification (real time QT-
NASBA) are also available [28,41], but they are mainly
being utilized for epidemiological studies rather than fa-
cilitating treatment.
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infections may leave a large part of the population with
untreated infections that may lead to persistent maternal
anaemia [42,43] and adverse consequences for the
foetus. Simple and easy to use malarial diagnostic tools
with adequate sensitivity such as RDTs are therefore
required [44] for effective management of PAM. As part
of a study entitled strategies to prevent pregnancy-
associated malaria (STOPPAM), a sub-study with the




A prospective cohort study on pregnant women was
conducted from September 2008 to October 2010.
Enrolled women had gestational age of ≤ 24 weeks, were
residents within an accessible area of Korogwe
District in order to facilitate follow up, had given written
informed consent to participate and were willing to
deliver at Korogwe District Hospital (KDH). After inclu-
sion, the cohort was followed up through three pre-
scheduled antenatal clinic visits (every 2–6 weeks
depending on gestational age) until delivery at KDH and
satellite outreach dispensaries within Korogwe District,
and they were also seen outside the pre-scheduled visits
(at any time) whenever necessary. Venous blood samples
were collected during each visit and placental blood at
delivery for detection of malaria parasites and evaluation
of haematological and other biological parameters.
Ultrasound sonography was performed at inclusion to
ascertain the gestational age and at each antenatal visit
to assess intrauterine foetal growth.
Study site
This study was carried out in Korogwe District, north-
eastern Tanzania. The district is inhabited by approxi-
mately 261,004 individuals, with a growth rate of 1.4%
per annum according to the 2002 Tanzanian human
population census report [45]. The district can be topo-
graphically stratified into lowland and highland zones,
and malaria transmission is perennial with the highest
transmission in the lowlands and after long rains [46,47]
and low transmission in the highlands at the onset of
short rains. P. falciparum is the dominant malaria spe-
cies transmitted by Anopheles gambiae s.s and Anopheles
funestus [48] with entomological inoculation rates of 91
infective bites/person per year [46]. The district has been
under constant surveillance of malaria since 2003. Of
late, there has been a progressive decline in malaria
parasite slide positivity rates in the area [49,50] that
transformed the area from hyper-endemic to meso/hypo
endemic. Obstetric care is provided at KDH, and at
other Health Centres and dispensaries within KorogweDistrict. More details about the study area can be found
in Mmbando et al. [49]. According to the 2004–2005
demographic and health survey (DHS) report, the cover-
age of intermittent preventive treatment during preg-
nancy with sulphadoxine-pyrimethamine (IPTp-SP) in
Tanga Region where Korogwe District is situated was
61.9% [51] as opposed to 90% during the STOPPAM
study indicating the importance of sensitization and its
impact on utilization of health services.
Ethical approval, sensitization meetings and informed
consent
The study protocol was approved by the Tanzania
Medical Research Coordinating Committee with refer-
ence number NIMR/HQ/R.8a/Vol. IX/688. Sensitization
meetings about the study goals and expectations were
held in all catchment villages. All procedures were con-
ducted in consistent with good clinical and laboratory
practices. All participants gave written informed consent.
Study samples
A cohort of 924 pregnant women was followed up from
enrolment until delivery, and a total of 5,905 samples
were collected. Of those, 5,167 venous and 388/650
placental blood samples, for which there were complete
RDT and microscopy datasets, were randomly selected
for analysis. The calculation of the sample size for the
primary study “STOPPAM” was based on the placental
hospital study that was previously conducted at KDH
and reported a placental parasite prevalence ranging
from 10 – 18%. The study screened 1,171 and excluded
176 pregnant women to have the final sample size of
995 pregnant women meeting the inclusion criteria for
enrolment. Seventy one pregnant women were lost to
follow up due to various reasons (Figure 1).
Blood drawing
Five to ten ml of venous blood was drawn at inclusion,
at scheduled and unscheduled antenatal clinic visits, and
just before/after delivery. Ten ml of unperfused placental
blood was also collected within 15 minutes of delivery
for women who gave birth at the labour ward of KDH.
The venous and placental blood for malaria thick and
thin blood smear preparations as well as filter paper
blood spots for DNA extraction were collected in
ethylenediamine-tetraacetic acid (EDTA) minicollect
tubes, whereas for RDTs whole blood was directly added
to the test device.
Malaria rapid diagnostic tests
Parascreen™ (Zephyr Biomedicals Goa, India) an RDT
that detects histidine rich protein 2 (HRP-2) antigen
from P. falciparum and parasite lactate dehydrogenase
(pLDH) from the Plasmodium species was used for
Figure 1 Consort flow diagram showing sampling strategy for different samples and their subsequent analyses. RDT: rapid diagnostic
test; +ve = positive; -ve: negative; PCR: polymerase chain reaction; KDH: Korogwe District hospital.
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samples were tested by Paracheck PfW (Orchid Biomed-
ical Systems –Mumbai, India) or ParaHITWf (Span diag-
nostics Ltd – Surat, India), the commonly available
RDTs in the study area. Paracheck PfW and ParaHITWf
only detect HRP-2 antigen from P. falciparum. All tests
were performed following the manufacturer’s instruc-
tions. The laboratory and clinical personnel were trained
on how to perform and interpret the RDTs results. As of
the 2011 WHO round 3 data on malarial RDTs perfor-
mances, all the RDTs used in this study have been
shown to perform well in all three rounds of testing
for performances.
Microscopic examination of thick and thin blood smears
Thick and thin blood smears from whole EDTA venous
and placental blood samples were prepared on glass slide,
air dried, stained for 30 minutes with 5% Giemsa stain,
then washed gently in tap water, air dried andfinally examined with a 100x objective lens under oil
immersion. Before a slide was declared negative 100
microscopical thick film fields were scanned. Asexual
parasite density was recorded as number of asexual stage
parasites per 200 leucocytes, and converted to parasite
count per microlitre, by using the actual count of leuco-
cytes as estimated by Sysmex KX-21 N haematological
analyser (Kobe, Japan). If the parasite count was less than
10, it was recorded per 500 leucocytes. All slides were read
twice by two independent experienced microscopists and
results from the two readings with a difference of less than
50% were considered definitive. Smears with discordant
results were re-examined by a third experienced micro-
scopist (blinded to the first two readings) and results from
two readers that were in agreement were considered final.
All laboratory technologists reading the blood slides parti-
cipated in the proficiency microscopy examination and
were certified by the National Institute for Communicable
Diseases (NICD), South Africa.
Table 1 Age, mean haemoglobin and parasite density of







Age in years (Mean± SD) 22.6 ± 4.2 30.7 ± 5.3
Mean haemoglobin level
(g/dL) [range]
10.45 [3.1 – 22.8] 10.53 [3.8 – 22.4]
Median asexual parasite
density/μl [range]
2090 [40–390748] 4163 [40–45760]
SD: standard deviation; dL: deciliter; μl: microlitre.
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In order to circumvent the problem of false negatives
due to the inability of microscopy in detecting sub-
microscopic infections or false positives due to the
detection of circulating HRP-2 antigen by RDT even
after parasite clearance, all the RDT positive but micros-
copy negative samples as well as a proportion of both
the RDT and microscopy negative samples were analysed
using nested Plasmodium species diagnostic PCR assay.
Fifty microlitre of EDTA blood was added on a premade
template of Whatman number 3 filter paper and allowed
to dry at room temperature and stored in silica gel to
preserve the DNA integrity. Briefly, half sector of the fil-
ter spot was excised and incubated with 0.5% saponin
(SIGMA™) in 1x PBS and incubated overnight to remove
the haemoglobin. The DNA was extracted by Chelex
100 resin method as explained by Wooden et al. [52]
with some modifications. The DNA supernatant was
carefully transferred to a new 96 wells PCR plate without
touching the Chelex 100 resin and stored at −20°C until
use. The parasite DNA was amplified by outer and
nested species diagnostic PCR according to Snounou
et al. [53] and the PCR products were analysed in 1.5%
ethidium bromide stained UltraPure™ agarose gel (Invi-
trogen) with a Gene ruler™ 50 bp DNA ladder (Lonza,
Belgium). The gels were visualized under UV trans-
illuminator from BIO-RAD.
Management of malaria
All women with confirmed malarial infection based on
RDTs and/or microscopy were treated with anti-malarial
drugs. Uncomplicated and asymptomatic infections were
treated by administration of quinine in the first trimester
and artemether-lumefantrine during the second or third
trimester.
Data management and analyses
All data were documented on case record forms and
double entered into Microsoft Access database, cleaned,
validated and transferred into R. version 2.12.0 statistical
package for analyses. Statistical significance level was
considered at α= 0.05. Baseline characteristics (demo-
graphic, clinical and parasitological) were analysed using
descriptive statistics. Sensitivity was defined as the pro-
portion of true malarial cases (positive blood smears
and/or PCRs) that were correctly identified by positive
RDTs whereas specificity was the proportion of true
negative malarial cases (negative blood smears/negative
PCRs) that were correctly identified by negative RDTs.
Positive predictive value was the proportion of true mal-
arial cases (positive blood smears and/or PCR) among
the individuals with the positive RDTs. Negative predict-
ive value was the proportion of true negative malarial
cases (negative blood smears/PCRs) among the totalnumber of negative RDT tests. Accuracy was defined as
the proportion of all tests that gave correct results (True
Positive +True Negative)/ number of all tests.
Results
In total, 1,171 pregnant women were screened, 995
(85%) met the inclusion criteria and were enrolled and
followed up. Seventy-one women were lost to follow up
or excluded before delivery due to spontaneous abortion
or moving out of the study area. Of the enrolled cohort,
924/995 (93%) successfully completed follow up, from
whom 5,555 blood samples with complete RDT and mi-
croscopy data were selected for further analyses (Fig-
ure 1). Of the enrolled cohort, 471 women were primi/
secundigravid and 524 were multigravid with mean ages
of 22.6 ± 4.2 and 30.7 ± 5.3 years for primi/secundigravid
and multigravid women, respectively. There were 899
successful live births among the 924 pregnant women
who successfully completed the follow up. P. falciparum
was the only malarial parasite detected by microscopy.
In women with a positive slide reading, the median asex-
ual parasite density/μl was 2,090 [range; 40–390,748]
and 4,163 [range; 40–45, 760] for primi-/secundigravid
and multigravid, respectively, (Table 1). 3,892 samples
were tested with Parascreen™, an RDT which detects
both P. falciparum and non-falciparum parasites. Thir-
teen samples (0.3% [95% CI: 0.2 – 0.6] were RDT posi-
tive for non-falciparum species, and of these 11 were also
RDT-positive for P. falciparum. As stated above non-fal-
ciparum parasites were not detected by slide reading and
the remaining part of the article only compares detection
of P. falciparum by the different methods employed since
it is the one mainly involved in PAM pathogenesis.
Comparison of rapid diagnostic test with microscopy results
Overall 91/5,555 (1.6% [1.3-2.0]) samples were positive
for malarial parasite antigen based on RDTs whereas 49/
5,555 (0.9% [95% CI; 0.7 –1.1]) were positive by micros-
copy (Table 2). Of the 91 RDT positive samples, 46
(50.5% [95% CI: 40.5 - 60.6] were microscopy positive
whilst 45 (49.5% [95% CI; 39.4 – 59.5]) were microscopy
Table 3 PCR analysis results of samples that were RDT
positive but microscopy negative




Parascreen™ 30 12 (40.0%) 18 (60.0%)
ParacheckPfW 9 6 (66.7%) 3 (33.3%)
ParaHITWf 6 1 (16.7%) 5 (83.3%)
Total 45 19 (42.2%) 26 (57.8%)
PCR: polymerase chain reaction; RDT: rapid diagnostic test.
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but RDT positive samples were genuinely negative or
false positive, a species diagnostic PCR assay was per-
formed. Three (0.05% [0.02 - 0.2]) samples were positive
by microscopy but negative by RDT. These samples were
not tested by PCR assay, but the slide readings were
confirmed by two independent expert slide readers as
positive with median parasite density of 224.75 [range;
86 – 486].
PCR confirmation of the RDT positive but microscopy
negative cases
The 45 RDT positive but microscopy negative samples
were checked by nested PCR to ascertain whether they
were sub-microscopic infections. Interestingly, 19/45
(42.2% [95% CI; 29.0 - 56.7] were positive by PCR
(Table 3).
Nested species diagnostic PCR correction of RDT and
microscopy negative samples
A proportion 351/650 (54%) of the available placental
blood samples that were malarial negative by both RDT
and microscopy were checked by nested PCR targeting
P. falciparum as it is the most prevalent species in the
study area and the one responsible for PAM pathology.
Only 650 placental blood samples could be collected due
to clotted placental blood (e.g. retained placenta or the
need for the project nurses to stay in the labour room to
resuscitate the newborn, delaying the transportation of
the placenta to the laboratory for processing) and 190
women gave birth outside the KDH setting making it
impossible to collect placental blood. Due to limited
resources and time, only a small proportion of all the
negative samples could be checked by PCR. The 351 pla-
cental instead of venous blood samples were randomly
selected as microscopy could have missed some parasites
in the peripheral blood due to parasite sequestration in
the placenta and also due to the presence of debris and
other contaminants in the placental blood that might
have resulted to poor quality blood smears not easily
readable. Interestingly, all these samples were negative
by PCR indicating that both microscopy and RDTs per-
formed equally well in diagnosing true negative cases.Table 2 Performance of different brands of rapid diagnostic t





Parascreen™ 3892 52 (1.3%) 3840 (98.7%) 28 (0.7
ParacheckWPf 594 19 (3.2%) 575 (96.8%) 8 (1.3
ParaHITWf 1069 20 (1.9%) 1049 (98.1%) 13 (1.8
Total 5555 91 (1.6%) 5464 (98.4%) 49 (0.9
RDT: rapid diagnostic test; μl: microlitre.Performance of different RDTs after PCR correction
The performance of the different RDTs and microscopy
was compared in the 442 samples in which PCR was
performed and using the PCR results as the golden
standard (Table 4). There was no statistically significant
difference between the performances of the different
RDTs. However, the study was not designed to directly
compare the different RDTs and these RDTs were not
employed on the same samples. All the PCR and slide
positive samples were P. falciparum. Probably the use of
a modified Snounou PCR using P. ovale. wallikeri and
P. ovale. curtisi primers might have increased the
number of positive PCRs and hence the overall perform-
ance of the RDTs.
Discussion
The performance of RDTs in diagnosing PAM was eval-
uated against microscopy and nested Plasmodium
species diagnostic PCR in a cohort of pregnant women
in north-eastern Tanzania. The use of RDTs might act
as an appropriate complementary diagnostic tool for
malaria instead of only relying on presumptive treatment
based on clinical grounds in areas with limited expert
microscopy and laboratory infrastructure. Prescription of
any drug during pregnancy is a challenging task due
to potential risks of harming the foetus [54], over-
prescription and subsequent risk of drug resistance de-
velopment [55]. Simple, cheap, reliable, accurate, easy to
use, sensitive and specific diagnostic tests that can iden-
tify genuine malarial cases are the only means of allow-
ing accurate malaria detection and rational treatment.
With the escalating anti-malarial drug resistance whichests in diagnosing PAM
Parasite density (asexual stages/μl)
Microscopy Median Range
ive Negative
%) 3864 (99.3%) 2565 39.5–101208
%) 586 (98.7%) 2004.5 581.5-23587.5
%) 1056 (98.8%) 1023.63 242.5–390748
%) 5506 (99.1%) 2090 40–390748
Table 4 Comparison of RDT and microscopy performance using PCR as golden standard in the 442 samples where PCR
results were available
Diagnostic category No. of
samples
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
% [95% CI] % [95% CI] % [95% CI] % [95% CI]
Parascreen™ 301 100.[89.9–100.0] 93.3 [89.6 -95.7] 65.4 [51.8-76.9] 100[98.5- 100.0]
Paracheck PfW 64 100 [8 0.6-100] 93.8 [83.2 – 97.9] 84.2 [62.4-94.5] 100 [92.1-100.0]
ParaHITWf 77 100 [79.6–100.0] 91.9 [82.5– 96.5] 75.0 [53.1 – 88.8] 91.9 [84.9-95.8]
Microscopy 442 70.8 [58.0 –81.1] 93.1[89.9-95.4] 63.9 [51.2-74.6] 94.5 [92.0–96.8]
PPV: positive predictive value; NPV: negative predictive value; 95% CI: 95% confidence interval.
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based combination therapy, there is a need to prescribe
anti-malarial drugs only to patients with true malarial ill-
ness [56]. The present study demonstrates that RDTs
can act as a diagnostic tool to manage malaria during
pregnancy in resource poor settings with limited access
to expert microscopy as they are easy to use and per-
form better than microscopy. Based on the PCR results,
the different types of RDTs used in this study were able
to capture over 40% of sub-microscopic infections
missed by microscopy.
According to the current Ministry of Health and Social
Welfare’s policy in Tanzania on malaria diagnosis, the
use of RDTs is not yet implemented as a routine practice
for pregnant women at antenatal clinics. Therefore,
there is a need to provide evidence-based data on the
best diagnostic supplement/alternative for malaria diag-
nosis during pregnancy in areas with limited laboratory
infrastructure. This will assist the National Malaria Con-
trol Programme in Tanzania and beyond when consider-
ing RDTs as a possible routine diagnostic tool in malaria
diagnosis during pregnancy. According to the recent
WHO report [57] on the performance of different RDTs,
it has been shown that they are easy to use, are heat
stable and have the ability to detect parasitaemia as low
as 200 asexual stages/μl. This makes RDTs an ideal diag-
nostic supplement to malaria diagnosis in resource con-
strained settings.
In many of the malaria endemic regions including
Tanzania, healthcare delivery in peripheral settings is
compromised by the lack of well equipped laboratories
and personnel with sufficient expertise in malaria mi-
croscopy [58]. Microscopy could be as sensitive as RDTs
or even more sensitive when done well. However,
adequate infrastructure, maintenance of good quality
microscopy and proper training on expert microscopy
are not always present in many malaria endemic settings.
Mismanagement of sub-microscopic infections could re-
sult in low but persistent parasitaemia that may
culminate in adverse pregnancy outcomes [42,43]. Under-
diagnosis and/or wrong diagnosis of true malarial infec-
tions may lead to infections going untreated or being
wrongly treated as non-malarial illnesses, withsubsequent adverse pregnancy outcomes and/or acting
as potential reservoirs of transmission. However, in all
malaria endemic settings, children with febrile illnesses
are treated by anti-malarials and/or other antimicrobials
following the World Health Organization guidelines’ on
integrated management of childhood illnesses.
Singer et al. [59] have shown that microscopy under-
estimates the real malarial burden during pregnancy.
Nonetheless in their study, contrary to this study, PCR
detected more positive cases as compared to RDTs,
whilst assessing only placental blood samples. The
present study might differ from that of Singer and col-
leagues in malaria transmission intensities and also in
the current study only a small proportion of RDT and
microscopy negative samples were checked by PCR due
to limited resources and time. However, when taken as a
proportion of placental blood the 351 samples checked
by PCR accounts for 54% of the available placental blood
samples with complete data. The message portrayed here
is that microscopy was shown to have underestimated
the true malarial prevalence after PCR correction.
The persistence of HRP-2 circulation in the blood
more than two weeks even after successful clearance of
IEs in the bloodstream is one of the concerns on the
usefulness of HRP-2 based RDTs in malaria diagnosis,
as has been reported by many studies [35,36,38,39,60].
However, in most of these studies microscopy was used
as gold standard without PCR correction and this might
have categorized sub-microscopic infections as false
positives due to the limited sensitivity of microscopy.
In the present study, all the RDT positive but microscopy
negative samples were checked by PCR and the analyses
showed that a large proportion of the RDT positive but
microscopy negative samples were in fact sub-
microscopic infections. Treatment of these few false
positive women with anti-malarials might provide some
prophylactic effect against subsequent infections out-
weighing the risk of not treating genuine sub-
microscopic infections missed by microscopy that could
have a profound effect on the pregnancy outcome. The
relatively poor performance of microscopy compared to
RDT cannot be explained by suboptimal conditions for
microscopy as the present study was conducted in
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tory conditions were excellent and all the laboratory
technologists had ample experience in malaria diagnosis
and were undergoing proficiency microscopy tests on a
regular basis.
The performance of RDTs in malaria diagnosis in
the present study is in agreement with studies by Tjitra,
Batwala and Tham et al. [26,27,62] showing that RDTs
were performing better than microscopy in malaria diag-
nosis under field conditions. Likewise, Bell et al. [38]
conducted a study in the Philippines in an area of low
endemicity and reported that sub-microscopic infections
missed by microscopy but captured by RDTs were actu-
ally true infections after PCR correction. On the other
hand, the current study is not in agreement with a study
by Schachterle et al. [63] that showed that RDTs had
high rates of false positives and negatives in a region of
hypoendemicity. However, the results of that study were
purely based on microscopy data without PCR correction.
RDTs missed some few infections, which were positive
in repeated microscopic investigations. This could be
due to assay degradation as a result of humid conditions
or batch variability of the RDTs [64], delay in HRP-2
surge after increased parasite density [38] or due to dele-
tion of hrp-2 genes in some parasites [60]. Some studies
have also reported reduced sensitivity of RDTs as a re-
sult of low parasitaemia [33,65] and this could explain
the reason for the few cases with low parasite densities
missed by RDTs [49,50].
This study indicates that RDTs outperform expert
microscopy in detecting asymptomatic P. falciparum in
pregnant women. Given the difficulties in establishing
reliable microscopy based diagnostic services, RDTs are
good alternative for the detection and in the manage-
ment of P. falciparum infections in pregnant women.
RDTs can both be used to detect infections not cleared
by IPTp or to detect infections where the malaria
endemicity is too low to warrant IPTp.
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